DermTech EBITDA Margin 2017-2024 | DMTKQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

DermTech ebitda margin from 2017 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

DermTech EBITDA Margin 2017-2024 | DMTKQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

DermTech ebitda margin from 2017 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$96B
Cencora (COR)	$46.2B
DiDi Global (DIDIY)	$23.8B
ICON (ICLR)	$18.2B
Natera (NTRA)	$15.4B
Avantor (AVTR)	$15.2B
Revvity (RVTY)	$14.9B
Viatris (VTRS)	$13.9B
BioMerieux (BMXMF)	$12.8B
Solventum (SOLV)	$12.5B
CochLear (CHEOY)	$12.3B
Medpace Holdings (MEDP)	$9.9B
Charles River Laboratories (CRL)	$9.3B
Sonic Healthcare (SKHHY)	$8.4B
Doximity (DOCS)	$7.9B
HealthEquity (HQY)	$7.5B
Bausch + Lomb (BLCO)	$7.2B
PACS (PACS)	$6.5B
Life Times (LTH)	$4.7B
Organon (OGN)	$4.7B
Sotera Health (SHC)	$4.5B
Surgery Partners (SGRY)	$3.7B
BrightSpring Health Services (BTSG)	$3B
Concentras Parent (CON)	$2.5B
Ardent Health Partners (ARDT)	$2.5B
Alignment Healthcare (ALHC)	$2.5B
GoodRx Holdings (GDRX)	$2.3B
GeneDx Holdings (WGS)	$2.1B
Premier (PINC)	$2B
Ryman Healthcare (RYHTY)	$1.9B